http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 13 Jul 2026 16:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++Cardio+Diagnostics+Holdi++For%3A+Sep+18/26762799.html si-local-file:///var/storage/secattach/20260713/26762799.html http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++Cardio+Diagnostics+Holdi++For%3A+Sep+18/26762799.html Mon, 13 Jul 2026 16:30:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++Cardio+Diagnostics+Holdi++For%3A+Sep+18/26762799.html si-local-file:///var/storage/secattach/20260713/26762799.html http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++Cardio+Diagnostics+Holdi++For%3A+Sep+18/26762799.html Mon, 13 Jul 2026 16:30:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Fung+Peter+K/26725939.html si-local-file:///var/storage/secattach/20260702/26725939.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Fung+Peter+K/26725939.html Thu, 02 Jul 2026 12:30:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Fung+Peter+K/26725939.html si-local-file:///var/storage/secattach/20260702/26725939.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Fung+Peter+K/26725939.html Thu, 02 Jul 2026 12:30:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Betts+Wendy+J/26725917.html si-local-file:///var/storage/secattach/20260702/26725917.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Betts+Wendy+J/26725917.html Thu, 02 Jul 2026 12:27:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Betts+Wendy+J/26725917.html si-local-file:///var/storage/secattach/20260702/26725917.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Betts+Wendy+J/26725917.html Thu, 02 Jul 2026 12:27:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Intrater+James/26725903.html si-local-file:///var/storage/secattach/20260702/26725903.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Intrater+James/26725903.html Thu, 02 Jul 2026 12:24:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Intrater+James/26725903.html si-local-file:///var/storage/secattach/20260702/26725903.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Intrater+James/26725903.html Thu, 02 Jul 2026 12:24:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Burton+Paul+Frederick/26725886.html si-local-file:///var/storage/secattach/20260702/26725886.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Burton+Paul+Frederick/26725886.html Thu, 02 Jul 2026 12:21:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Burton+Paul+Frederick/26725886.html si-local-file:///var/storage/secattach/20260702/26725886.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Jun+30++Filed+by%3A+Burton+Paul+Frederick/26725886.html Thu, 02 Jul 2026 12:21:00 -0400 CDIO O.52968319 http://www.streetinsider.com/Press+Releases/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=41e7d6be8d7cf84774bf2c3a578c9153" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ahpscipa.com%2Findex.php&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Atlas+Healthcare+Physicians+%28AHP%29&amp;index=2&amp;md5=48e4385552d03fff9ec889b866276f46" shape="rect">Atlas Healthcare Physicians (AHP)</a>, a community-driven, independent physician association (IPA) based in Southern California, will cover Cardio Diagnostics’ tests, Epi+Gen CHD™ and PrecisionCHD™, for their members with prior authorization beginning May 2026. AHP consists of an expansive network of primary care and specialists, hospitals, and ancillary providers serving managed care populations across Los Angeles and Orange County. </p><p> Providers will recommend Epi+Gen CHD™ or PrecisionCHD™ based on a patient’s medical history. Epi+Gen CHD™ assesses the http://www.streetinsider.com/Press+Releases/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html Wed, 24 Jun 2026 08:35:00 -0400 A.21069230 CDIO O.22006724 O.52968319 http://www.streetinsider.com/Press+Releases/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=41e7d6be8d7cf84774bf2c3a578c9153" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ahpscipa.com%2Findex.php&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Atlas+Healthcare+Physicians+%28AHP%29&amp;index=2&amp;md5=48e4385552d03fff9ec889b866276f46" shape="rect">Atlas Healthcare Physicians (AHP)</a>, a community-driven, independent physician association (IPA) based in Southern California, will cover Cardio Diagnostics’ tests, Epi+Gen CHD™ and PrecisionCHD™, for their members with prior authorization beginning May 2026. AHP consists of an expansive network of primary care and specialists, hospitals, and ancillary providers serving managed care populations across Los Angeles and Orange County. </p><p> Providers will recommend Epi+Gen CHD™ or PrecisionCHD™ based on a patient’s medical history. Epi+Gen CHD™ assesses the http://www.streetinsider.com/Press+Releases/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html Wed, 24 Jun 2026 08:35:00 -0400 A.21069230 CDIO O.22006724 O.52968319 http://www.streetinsider.com/Press+Releases/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=41e7d6be8d7cf84774bf2c3a578c9153" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ahpscipa.com%2Findex.php&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Atlas+Healthcare+Physicians+%28AHP%29&amp;index=2&amp;md5=48e4385552d03fff9ec889b866276f46" shape="rect">Atlas Healthcare Physicians (AHP)</a>, a community-driven, independent physician association (IPA) based in Southern California, will cover Cardio Diagnostics’ tests, Epi+Gen CHD™ and PrecisionCHD™, for their members with prior authorization beginning May 2026. AHP consists of an expansive network of primary care and specialists, hospitals, and ancillary providers serving managed care populations across Los Angeles and Orange County. </p><p> Providers will recommend Epi+Gen CHD™ or PrecisionCHD™ based on a patient’s medical history. Epi+Gen CHD™ assesses the http://www.streetinsider.com/Press+Releases/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html Wed, 24 Jun 2026 08:35:00 -0400 A.21069230 CDIO O.22006724 O.52968319 http://www.streetinsider.com/Press+Releases/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=41e7d6be8d7cf84774bf2c3a578c9153" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ahpscipa.com%2Findex.php&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Atlas+Healthcare+Physicians+%28AHP%29&amp;index=2&amp;md5=48e4385552d03fff9ec889b866276f46" shape="rect">Atlas Healthcare Physicians (AHP)</a>, a community-driven, independent physician association (IPA) based in Southern California, will cover Cardio Diagnostics’ tests, Epi+Gen CHD™ and PrecisionCHD™, for their members with prior authorization beginning May 2026. AHP consists of an expansive network of primary care and specialists, hospitals, and ancillary providers serving managed care populations across Los Angeles and Orange County. </p><p> Providers will recommend Epi+Gen CHD™ or PrecisionCHD™ based on a patient’s medical history. Epi+Gen CHD™ assesses the http://www.streetinsider.com/Press+Releases/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html Wed, 24 Jun 2026 08:35:00 -0400 A.21069230 CDIO O.22006724 O.52968319 http://www.streetinsider.com/Business+Wire/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=41e7d6be8d7cf84774bf2c3a578c9153" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ahpscipa.com%2Findex.php&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Atlas+Healthcare+Physicians+%28AHP%29&amp;index=2&amp;md5=48e4385552d03fff9ec889b866276f46" shape="rect">Atlas Healthcare Physicians (AHP)</a>, a community-driven, independent physician association (IPA) based in Southern California, will cover Cardio Diagnostics’ tests, Epi+Gen CHD™ and PrecisionCHD™, for their members with prior authorization beginning May 2026. AHP consists of an expansive network of primary care and specialists, hospitals, and ancillary providers serving managed care populations across Los Angeles and Orange County. </p><p> Providers will recommend Epi+Gen CHD™ or PrecisionCHD™ based on a patient’s medical history. Epi+Gen CHD™ assesses the http://www.streetinsider.com/Business+Wire/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html Wed, 24 Jun 2026 08:35:00 -0400 A.21069230 CDIO O.22006724 O.52968319 http://www.streetinsider.com/Business+Wire/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=41e7d6be8d7cf84774bf2c3a578c9153" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ahpscipa.com%2Findex.php&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Atlas+Healthcare+Physicians+%28AHP%29&amp;index=2&amp;md5=48e4385552d03fff9ec889b866276f46" shape="rect">Atlas Healthcare Physicians (AHP)</a>, a community-driven, independent physician association (IPA) based in Southern California, will cover Cardio Diagnostics’ tests, Epi+Gen CHD™ and PrecisionCHD™, for their members with prior authorization beginning May 2026. AHP consists of an expansive network of primary care and specialists, hospitals, and ancillary providers serving managed care populations across Los Angeles and Orange County. </p><p> Providers will recommend Epi+Gen CHD™ or PrecisionCHD™ based on a patient’s medical history. Epi+Gen CHD™ assesses the http://www.streetinsider.com/Business+Wire/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html Wed, 24 Jun 2026 08:35:00 -0400 A.21069230 CDIO O.22006724 O.52968319 http://www.streetinsider.com/Business+Wire/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=41e7d6be8d7cf84774bf2c3a578c9153" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ahpscipa.com%2Findex.php&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Atlas+Healthcare+Physicians+%28AHP%29&amp;index=2&amp;md5=48e4385552d03fff9ec889b866276f46" shape="rect">Atlas Healthcare Physicians (AHP)</a>, a community-driven, independent physician association (IPA) based in Southern California, will cover Cardio Diagnostics’ tests, Epi+Gen CHD™ and PrecisionCHD™, for their members with prior authorization beginning May 2026. AHP consists of an expansive network of primary care and specialists, hospitals, and ancillary providers serving managed care populations across Los Angeles and Orange County. </p><p> Providers will recommend Epi+Gen CHD™ or PrecisionCHD™ based on a patient’s medical history. Epi+Gen CHD™ assesses the http://www.streetinsider.com/Business+Wire/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html Wed, 24 Jun 2026 08:35:00 -0400 A.21069230 CDIO O.22006724 O.52968319 http://www.streetinsider.com/Business+Wire/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=41e7d6be8d7cf84774bf2c3a578c9153" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ahpscipa.com%2Findex.php&amp;esheet=54559164&amp;newsitemid=20260624992562&amp;lan=en-US&amp;anchor=Atlas+Healthcare+Physicians+%28AHP%29&amp;index=2&amp;md5=48e4385552d03fff9ec889b866276f46" shape="rect">Atlas Healthcare Physicians (AHP)</a>, a community-driven, independent physician association (IPA) based in Southern California, will cover Cardio Diagnostics’ tests, Epi+Gen CHD™ and PrecisionCHD™, for their members with prior authorization beginning May 2026. AHP consists of an expansive network of primary care and specialists, hospitals, and ancillary providers serving managed care populations across Los Angeles and Orange County. </p><p> Providers will recommend Epi+Gen CHD™ or PrecisionCHD™ based on a patient’s medical history. Epi+Gen CHD™ assesses the http://www.streetinsider.com/Business+Wire/Atlas+Healthcare+Physicians+to+Cover+Cardio+Diagnostics%E2%80%99+Precision+Cardiovascular+Medicine+Tests+Across+Its+Network/26682712.html Wed, 24 Jun 2026 08:35:00 -0400 A.21069230 CDIO O.22006724 O.52968319 http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319